Document:

Exhibit 10.26  

[Epocrates,
Inc. Letterhead] 

October 8,
2010

Dave
Burlington 

Re:    Employment
Terms 

Dear
Dave, 

        On
behalf of Epocrates, Inc. ("Epocrates" or the "Company"), I am pleased to offer
you the full-time position of Chief Operations Officer. The terms and conditions of your new position and employment relationship with the Company are as set forth below: 

        1.    Position and Work Schedule.    

        a.     You
will become the Chief Operations Officer for the Company. You will report directly to the Chief Executive Officer and work out of the Company's San Mateo, California
office. This is a full-time position. 

        b.     You
agree to the best of your ability and experience that you will at all times conscientiously perform all of the duties and obligations required of you to the
satisfaction of the Company. During the term of your employment, you further agree that you will devote your full business time and attention to the business of the Company, the Company will be
entitled to all of the benefits and profits arising from or incident to all such work services and advice, you will not render commercial or professional services of any nature to any person or
organization, or engage in self-employment, whether or not for compensation, without the prior written consent of the Company, and you will not directly or indirectly engage or participate
in any business that is competitive in any manner with the business of the Company. Nothing in this letter agreement will prevent you from accepting speaking or presentation engagements in exchange
for honoraria or from serving on boards of charitable organizations, or from owning no more than one percent (1%) of the outstanding equity securities of a corporation whose stock is listed on a
national stock exchange. 

        c.     Of
course, the Company may change your position, duties, reporting relationship and office location from time to time in its discretion. 

        2.    Start Date.    Subject to fulfillment of any conditions imposed by this letter
agreement, you will commence this new position with the Company on November 11, 2010 or any other mutually agreeable date (the "Start Date"). 

        3.    Proof of Right to Work.    For purposes of federal immigration law, you will be required
to provide to the Company documentary proof of your identity and eligibility for employment in the United States. This offer of employment is contingent upon such satisfactory proof. 

        4.    Compensation.    

        a.    Base Salary.    Your initial base salary will be payable in semi monthly installments of
$11,250.00 pursuant to the Company's regular payroll policy, which equates to an annual base salary of $270,000. Because your position is classified as exempt, you will not be eligible for overtime
premiums or additional compensation for working "overtime." Your base salary may be reviewed annually as part of the Company's normal salary review process. Any changes to your base salary are at the
Company's sole discretion. 

        b.    Bonus Compensation.    You will be eligible to participate in the 2010 Executive Bonus
Plan (the "Bonus Plan"), pursuant to the terms and conditions of the Bonus Plan. Your target bonus under the Bonus Plan will be 60% of your 2010 base
salary paid by the Company, and the actual bonus paid will be based upon the Company's performance (as determined by the Company) 

against
the Bonus Plan. No bonus is considered earned under the Bonus Plan until the time that such bonus is scheduled to be paid as provided under the Bonus Plan. Thus, in the event that your
employment has been terminated (either by the Company or by you), you will not be entitled to any bonus which has not been scheduled to be paid prior to the termination date. Any bonus for 2010 will
be prorated based on your Start Date. Whether a bonus has been earned under the Bonus Plan, and the amount of any bonus earned, will be determined by the Company and approved by the Company's Board of
Directors (the "Board") within its sole discretion. Any bonus earned will be paid as soon as practicable following the approval of the Bonus Plan
payouts by the Board, as provided under the Bonus Plan. 

        5.    Stock Option.    In connection with the commencement of your employment, the Company
will recommend that the Board grant you an option to purchase three hundred ten thousand, nine hundred twenty-four (310,924) shares of the Company's Common Stock (the
"Shares") under the Company's 2008 Equity Incentive Plan (the "Plan") with an exercise price equal to
the fair market value on the date of the grant as determined by the Board (the "Option"). The Option will be subject to the terms of the Plan and your
individual Stock Option Agreement with the Company, which shall include the following five-year vesting schedule applicable to the Shares: twenty percent (one-fifth) of the
Shares shall vest on the first annual anniversary of the Start Date, and 1/60th of the Shares shall vest monthly thereafter over the next four years. Vesting will, of course,
depend on your continued service with the Company, as defined by the Plan. The Option will be an incentive stock option to the maximum extent allowed by the tax code. 

        6.    Benefits.    Subject to the terms, conditions and limitations of the benefit plans, you
will be eligible to participate in the Company's standard employee benefits currently consisting of short/long term disability, medical, dental, and vision insurance benefits. Eligibility for
participation in these group benefits will become effective the first of the month following your Start Date. Regular full-time and part-time exempt employees do not accrue
vacation, sick leave, or other paid time off, and there is no set guideline on how much time off employees will be permitted to take. Under the terms of the Company's paid time off policy for exempt
employees, you will be permitted to take a reasonable amount of time off with pay, as permitted by your duties and responsibilities, and as approved in advance by your manager. Further details about
benefits are available for your review. Epocrates may modify compensation and benefits from time to time at its discretion. 

        7.    Employee 401(k) Plan.    You will be eligible to participate in Epocrates' 401(K) plan
beginning on the first of the month following your Start Date. Employees who choose to participate will have pre-tax dollars deposited into their 401(K) account and the money will be
directed to specified investment options. Epocrates does not match funds or make contributions. 

        8.    Confidential Information and Invention Assignment Agreement.    Your acceptance of this
offer and commencement of employment with the Company is contingent upon the execution, and delivery to an officer of the Company, of the Company's Confidential Information and Invention Assignment
Agreement (the "Confidentiality Agreement"), a copy of which is enclosed for your review and execution, prior to or on your Start Date. You are also
required to abide by the Confidentiality Agreement as a condition of your employment. In your work for the Company, you will be expected not to use or disclose any confidential information, including
trade secrets, of any former employer or other person to whom you have an obligation of confidentiality. Rather, you may use only that information generally known and used by persons with training and
experience comparable to your own, which is common knowledge in the industry or otherwise legally in the public domain, or which is otherwise provided or developed by the Company, or developed by you
on behalf of the Company. You agree that you will not bring onto Company premises any unpublished documents or property belonging to any former employer or other person to whom you have an obligation
of confidentiality. You represent further that you have disclosed to the Company any contract you have signed that may restrict your activities on behalf of the Company. 

        9.    Company Policies.    As a condition of your employment, you will be expected to abide by
the Company policies and procedures, and acknowledge in writing that you have read and will comply with the Company's Employee Handbook. 

        10.    At-Will Employment.    Your employment with the Company will be on an "at
will" basis, meaning that either you or the Company may terminate your employment at any time, with or without cause, and with or without advance notice. Your employment at-will status can
only be modified in a written agreement signed by you and by a duly authorized officer of the Company. 

        11.    Severance Benefits Not In Connection With A Change of Control.    If, at any time other
than during the twelve (12) months following the consummation of a Change of Control (as defined herein), the Company or any successor entity terminates your employment without Cause (as
defined herein), and if, on or within thirty (30) days after the termination date, you sign, date, and deliver to the Company a separation agreement that includes a general release of all known
and unknown claims in the form provided to you by the Company (the "Release") and you do not subsequently revoke the Release, then you will receive the
following as your sole severance benefits (the "Severance Benefits"): (i) severance pay equal to six (6) months of your base salary in
effect as of the termination date, less required deductions and withholdings, paid in the form of salary continuation on the Company's standard payroll dates beginning with the first payroll date
following the thirtieth day after the termination date (provided that the Release has become effective by such payroll date, and the initial severance payment will be a "catch-up" payment
that provides the full amount of severance pay that you would have received if the severance payments had begun as of the first payroll date following the termination date); and (ii) provided
that you timely elect continued group health insurance coverage through federal COBRA law or comparable state law (collectively, "COBRA"), the Company
will pay
your COBRA premiums sufficient to continue your group health insurance coverage at the same level in effect as of your termination date for six (6) months after your termination or until you
become eligible for group health insurance coverage through a new employer, whichever occurs first. For purposes of this letter agreement, "Cause" means
any of the following conduct by you: (i) embezzlement, misappropriation of corporate funds, or other material acts of dishonesty; (ii) the conviction, plea of guilty, or nolo contendere
to any felony (not involving the operation of a motor vehicle), or of any misdemeanor involving moral turpitude; (iii) engagement in any activity that you know or should know could materially
harm the business or reputation of the Company, provided that this subsection (iii) shall not apply to any activity done in a good faith belief by you that the action taken or omission was in
the best interest of the Company; (iv) material violation of any statutory, contractual, or common law duty or obligation owed by you to the Company, including, without limitation, the duty of
loyalty which causes demonstrable injury to the Company; (v) material breach of the Confidentiality Agreement; or (vi) repeated failure, in the reasonable judgment of the Company, to
substantially perform your assigned duties or responsibilities after written notice from the Company describing the failure(s) in reasonable detail and your failure to cure such failure(s) within
thirty (30) days of receiving such written notice, provided that written notice only must be provided if the failure(s) are capable of cure. 

        12.    Change of Control Severance Benefits.    In the event that: (i) the Company
consummates a change of control transaction, whereby fifty percent (50%) or more of the voting stock of the Company changes ownership pursuant to such transaction (a "Change of
Control"); and (ii) within twelve (12) months after the consummation of a Change of Control, your employment with the Company is either (a) terminated by
the Company or successor entity without Cause, or (b) terminated by you for Good Reason (as defined in and in accordance with the paragraph below); and (iii) if, on or within thirty
(30) days after the termination date, you sign, date, and deliver to the Company the Release and you do not subsequently revoke the Release; then you will receive the following as your sole
severance benefits (the "Change of Control Severance Benefits"): (a) severance pay equal to nine (9) months of your base salary in effect
as of the termination date, less required deductions and withholdings, paid in the form of salary continuation on the Company's standard payroll dates beginning with the first payroll date following
the thirtieth day after the termination date (provided that the Release has become effective by such payroll date, and the initial severance payment will be a "catch-up" payment 

that
provides the full amount of severance pay that you would have received if the severance payments had begun as of the first payroll date following the termination date); (b) provided that
you timely elect continued group health insurance coverage through COBRA, the Company will pay your COBRA premiums sufficient to continue your group health insurance coverage at the same level in
effect as of your termination date for nine (9) months after your termination or until you become eligible for group health insurance coverage through a new employer, whichever occurs first;
and (c) any unvested shares subject to any option grants held by you as of the employment termination date will become vested, effective as of the employment termination date. 

        For
purposes of this Section 12, "Good Reason" shall mean one or more of the following conditions that arose upon or following the
consummation of the Change of Control without your written consent: (i) a relocation of your assigned office which results in an increase in your one-way commuting distance by more
than thirty-five (35) miles; (ii) a material decrease in your base salary (except for salary decreases generally applicable to the Company's other executive
employees); or (iii) a material reduction in the scope of your duties or responsibilities from your duties and responsibilities in effect immediately prior to the Change of Control.
Notwithstanding the foregoing, you shall not be deemed to have terminated your employment for "Good Reason" unless (i) such termination occurs within ninety (90) days following the
initial existence of one or more of the conditions that constitute Good Reason (as defined herein), (ii) you provide written notice to the Company (or any successor entity) of the existence of
the Good Reason condition within thirty (30) days following the initial existence of the condition, and (iii) the Company (or its successor entity) fails to cure such condition within a
period of thirty (30) days following such written notice. 

        13.    Parachute Payments.    In the event that the benefits provided for in this letter
agreement or otherwise payable to you ("Payment") would constitute "parachute payments" within the meaning of Section 280G of the Internal
Revenue Code of 1986, as amended (the "Code") and, but for this sentence, would be subject to the excise tax imposed by Section 4999 of the Code
(the "Excise Tax"), then such Payment shall be equal to the Reduced Amount. The "Reduced Amount" shall
be either (i) the largest portion of the Payment that would result in no portion of the Payment being subject to the Excise Tax, or (ii) the largest portion, up to and including the
total, of the Payment, whichever of the foregoing amounts, after taking into account all applicable federal, state and local employment taxes, income taxes and the Excise Tax (all computed at the
highest applicable marginal rate), results in the receipt by you, on an after-tax basis, of the greater amount of the Payment, notwithstanding that all or some portion of the Payment may
be subject to the Excise Tax. Unless the Company and you otherwise agree in writing, the determination of your Excise Tax liability shall be made in writing by the accounting firm engaged by the
Company for general audit purposes as of the day prior to the effective date of the Change of Control (the "Accountants"). If the accounting firm so
engaged by the Company is serving as accountant or auditor for the individual, entity or group effecting the Change of Control, the Company shall appoint a nationally recognized accounting firm to
make the determinations required hereunder. For purposes of making the calculations required by this Section 13, the Accountants may make reasonable assumptions and approximations concerning
applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. Any good faith determinations of the Accountants made
hereunder shall be final, binding, and conclusive upon the Company and you. The Company and you shall furnish to the Accountants such information and documents as the Accountants may reasonably
request in order to make a determination under this Section. The Company shall bear all costs the Accountants may reasonably incur in connection with any calculations contemplated by this
Section 13. To the extent that any elimination in or reduction of payments or benefits is made under this Section 13, the order in which payments and benefits shall be reduced shall be
made by the Accountants in a manner that shall provide you with the greatest economic benefit, but if more than one manner of reduction of payments and benefits necessary to arrive at the Reduced
Amount yields the greatest economic benefit to you, then the payments and benefits shall be reduced pro rata. 

        14.    Deferred Compensation.    Severance payments made pursuant to Section 11 or
Section 12, to the extent of payments made from the date of your termination through March 15 of the calendar year 

following
your termination, are intended to constitute separate payments for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations and thus payable pursuant to the
"short-term deferral" rule set forth in Section 1.409A-1(b)(4) of the Treasury Regulations. To the extent such payments are made following said March 15, they are
intended
to constitute separate payments for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations made upon an involuntary termination from service and payable pursuant to
Section 1.409A-1(b)(9)(iii) of the Treasury Regulations, to the maximum extent permitted by such provision, with any excess amount being regarded as subject to the distribution
requirements of Section 409A(a)(2)(A) of the Code, including, without limitation, the requirement of Section 409A(a)(2)(B)(i) of the Code that payment be delayed until six
(6) months after separation from service if you are a "specified employee" within the meaning of Section 409A(a)(2)(B)(i) of the Code at the time of such separation from service.
Notwithstanding anything to the contrary set forth herein, if any payments and benefits provided under this Agreement constitute "deferred compensation" within the meaning of Section 409A of
the Code and the regulations and other guidance thereunder and any state law of similar effect (collectively "Section 409A") (i) such
payments and benefits shall not commence in connection with your termination of employment unless and until you also have incurred a "separation from service" (as such term is defined in Treasury
Regulations Section 1.409A-1(h)), unless the Company reasonably determines that such amounts may be provided to you without causing you to incur the adverse personal tax
consequences under Section 409A, and (ii) the Release required by Sections 11 and 12 above shall be considered effective only as of the latest permitted effective date for such
Release if such Release could become effective in the calendar year following the calendar year in which your employment termination occurs. 

        15.    Complete Agreement.    This letter, together with your Confidentiality Agreement, forms
the complete and exclusive statement of your employment agreement with the Company. The terms in this letter supersede any other agreements or promises made to you by anyone, whether oral or written.
Other than those changes expressly reserved to the Company's discretion in this letter, this letter agreement cannot be changed except in a written agreement signed by you and a duly authorized
officer of the Company. 

        This
offer and your employment are subject to a satisfactory background check, and you agree to cooperate fully with the Company in completing any requested authorizations for the
background check. 

        We
are all delighted to be able to extend you this offer and look forward to working with you. To indicate your acceptance of the Company's offer, please sign and date this letter in the
space provided below and return it to me, along with a signed and dated copy of the Confidentiality Agreement. 

        This
offer is valid until October 15, 2010. 

Very
truly yours,

Epocrates, Inc. 

/s/
John S. Owens 

John
S. Owens 

Senior
Vice President

Human Resources 

 UNDERSTOOD, ACCEPTED AND AGREED:  

 Dave Burlington  

 

 

			
	/s/ Dave Burlington

  Signature	 	 
	10/13/10

  Date	 	 
	11/11/10

  Start Date	 	 

 

 Enclosure:    Confidentiality
AgreementExhibit 10.27  

EPOCRATES, INC.

2008 EQUITY INCENTIVE PLAN  

 OPTION GRANT NOTICE  

        Epocrates, Inc. (the "Company"), pursuant to its 2008 Equity Incentive Plan (the
"Plan"), hereby grants to Optionholder an option to purchase the number of shares of the Company's Common Stock set forth below. This option is subject
to all of the terms and conditions as set forth herein and in the Option Agreement, the Plan, and the Notice of Exercise, all of which are attached hereto and incorporated herein in their entirety. 

 

 

					
	Optionholder:	 	 	 	

 
	Date of Grant:	 	 	 	

 
	Vesting Commencement Date:	 	 	 	

 
	Number of Shares Subject to Option:	 	 	 	

 
	Exercise Price (Per Share):	 	 	 	

 
	Total Exercise Price:	 	 	 	

 
	Expiration Date:	 	 	 	

 

 

 

 

					
	Type of Grant	 	Nonstatutory Stock Option.
	Exercise Schedule:	 	Same as Vesting Schedule.
	Vesting Schedule:	 	Shares subject to the Option shall vest in accordance with the terms set forth on Schedule A.
	Payment:	 	By one or a combination of the following items (described in the Option Agreement):
	 	 	ý	 	By cash or check
	 	 	ý	 	Pursuant to a Regulation T Program if the Shares are publicly traded
	 	 	ý	 	By delivery of already-owned shares if the Shares are publicly traded
	 	 	ý	 	By net exercise, if the Company has established procedures for net exercise

 

          Additional Terms/Acknowledgements:    The undersigned Optionholder acknowledges receipt of, and understands and agrees to, this Option
Grant Notice, the
Option Agreement, and the Plan. Optionholder further acknowledges that as of the Date of Grant, this Option Grant Notice, the Option Agreement, and the Plan set forth the entire understanding between
Optionholder and the Company regarding the acquisition of stock in the Company and supersede all prior oral and written agreements on that subject with the exception of (i) options previously
granted and delivered to Optionholder under the Plan, and (ii) the following agreements only:

 

 

			
	OTHER AGREEMENTS:	 	None

 
	  	 	

 

 

 

 

									
	
 	
EPOCRATES, INC.	
 	
 	
 [                        ]
	
 	
 By:	
 	

  Signature	
 	
 	

  Signature
	
 	
 Title:	
 	

 	
 	
 	
Date:	
 	
  

 
	 	Date:	 	

 	 	 	 	 	 
	
 	
ATTACHMENTS: Option Agreement, 2008 Equity Incentive Plan and Notice of Exercise

 

 

 SCHEDULE A  

 2010 PERFORMANCE-BASED STOCK OPTION GRANT NOTICE  

 

 

							
	Shares subject to Performance Based Option

 
	 	Weight Value 	 	100% Payout 	 	125% Payout 
	 2010 Bookings
	 	[                        ]	 	[                        ]	 	[                        ]
	 2010 Revenue
	 	[                        ]	 	[                        ]	 	[                        ]
	 EBITDA
	 	[                        ]	 	[                        ]	 	[                        ]
	 Launch of beta test of EHR product
	 	[                        ]	 	[                        ]	 	[                        ]
	 	 	 	 	 	 	 
	 Total
	 	[                        ]	 	[                        ]	 	[                        ]

 

         The
Epocrates, Inc. (the "Company") 2010 bookings ("Bookings"), 2010 revenue
("Revenue") and earnings before interests, taxes, depreciation and amortization, as adjusted for certain non-cash items in accordance with
the Company's business plan and as determined by the Audit Committee of the Board ("EBITDA") goals are as set forth below on Table A below. The
goals in connection with the launch of the beta test of the EHR product will be determined at the sole discretion by the Board or Compensation Committee of the Board ("Beta
Test," and together with the Bookings, Revenue and EBITDA, the "Metrics"). 

 Table A  

 

																												
	 	BOOKINGS	 	REVENUE	 	EBITDA 	 
	 	% of Plan

 
	 	2010 Plan

(in $M) 	 	Payout % 	 	% of Plan 	 	2010 Plan

(in $M) 	 	Payout % 	 	% of

Plan 	 	2010 Plan

(in $M) 	 	Payout % 	 
	 	 	  £ 75%	 	 	74.8	 	 	0%	 	 	£ 90%	 	 	90.7	 	 	0%	 	 	£ 70%	 	 	15.7	 	 	0%	 
	 	 	    100%	 	 	99.7	 	 	100%	 	 	100%	 	 	100.8	 	 	100%	 	 	100%	 	 	22.4	 	 	100%	 
	 	 	3 105%	 	 	104.7	 	 	125%	 	 	3 105%	 	 	105.8	 	 	125%	 	 	3 115%	 	 	25.7	 	 	125%	 

 

         On
the date the 2010 financial results for the Company are available and the Compensation Committee of the Board determines, in its sole discretion, (i) the percentage of plan
achieved by the Company for each of the Metrics (the "Payout Determination Date") and (ii) the corresponding number of shares
("Milestone Shares") achieved with each of the Metrics (prorated in the event performance falls between points on Table A and with respect to the
Beta Test, at the sole discretion of the Board or Compensation Committee of the Board, and rounded to the nearest whole number). Each of the above Metrics will be assigned its own weight value in
determining the Milestone Shares. The Milestone Shares shall be subject to vesting at the rate of 1/36th of the Milestone Shares per month commencing on January 1, 2011
(the "Vesting Commencement Date"); provided, however, that vesting will cease upon the termination of
Optionholder's Continuous Service. For the avoidance of doubt, any shares that would have vested in connection with this vesting schedule between the Vesting Commencement Date and the Payout
Determination Date will first vest on the Payout Determination Date. The balance of the shares granted but not included in the Milestone Shares shall revert to and again become available for issuance
under the 2008 Equity Incentive Plan. Further, no shares subject to the Option are exercisable until the Payout Determination Date. 

        For
example, in order for Optionholder to achieve vesting of the number of shares specified at the 100% Payout level in the table above, the Company must achieve 100% of plan for
Bookings, Revenue and EBITDA, such that [            ] Milestone Shares will commence vesting for each of Bookings, Revenue and EBITDA on the Payout Determination Date and
the Board must determine in its sole discretion that 100% of plan for the goals in connection with the Beta Test was achieved, such that
[                        ] Milestone Shares will
commence vesting on the Payout Determination Date. The Milestone Shares shall be subject to continued vesting at the rate of 1/36th of the Milestone Shares per month commencing
effective on the Vesting Commencement Date. The balance of the shares not included in the Milestone Shares shall revert to and again become available for issuance under the 2008 Equity Incentive Plan. 

        In
the event, the Company achieves 75% of plan or less for Bookings, 90% of plan or less for Revenue and 70% of plan or less for EBITDA and the Board or Compensation Committee of the
Board determines in its sole discretion that less than 100% of plan for the goals in connection with the Beta
Test is achieved, the Optionholder will not vest any of the shares for any of the Metrics, no shares will vest on the Payout Determination Date and all the Shares shall revert to and again become
available for issuance under the 2008 Equity Incentive Plan. 

        Similarly,
in the event the Company achieves 105% of plan or greater for Bookings and Revenue and 115% of plan or greater for EBITDA, the Optionholder will commence vesting as to 125% of
[                        ] Milestone Shares, or
[                        ] Milestone Shares for each of Bookings, Revenue and EBITDA, such that an aggregate of
[                        ] Milestone Shares will commence vesting on the Payout Determination Date, and the Board or Compensation
Committee of the Board determines in its sole
discretion that 125% of plan of goals in connection with the Beta Test is achieved, such that [                        ] Milestone
Shares will commence vesting on the Payout
Determination Date. Such Milestone Shares shall be subject to continued vesting at the rate of 1/36th of the Milestone Shares per month commencing effective on the Vesting
Commencement Date.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00181-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00181-of-00352.parquet"}]]